CRESP 40MCG/ 0.4 ML Injection

Price 2400 INR/ Thousand

Get a Price/Quote

MOQ : 5 Vials

CRESP 40MCG/ 0.4 ML Injection Specification

Indication
Treatment of anemia associated with chronic renal failure, anemia in cancer patients undergoing chemotherapy

Dosage Form
Injection

Pacakaging (Quantity Per Box)
1 pre-filled syringe per box

Salt Composition
Darbepoetin alfa 40 mcg

Origin of Medicine
India

Drug Type
Biological/biotech recombinant protein

Ingredients
Darbepoetin alfa (recombinant human erythropoietin analogue) 40 mcg

Physical Form
Injection (pre-filled syringe)

Function
Stimulates red blood cell production

Recommended For
Anemia due to chronic kidney disease, chemotherapy-induced anemia

Dosage
As directed by the physician, typically administered once weekly or as prescribed

Dosage Guidelines
Administer subcutaneously or intravenously as instructed by healthcare provider

Suitable For
Adults and pediatric patients (as directed by physician)

Quantity
0.4 ml per prefilled syringe

Storage Instructions
Store at 2C to 8C (Refrigerate). Do not freeze. Protect from light.

Prescription/Non Prescription
Prescription Only

Packaging Type
Pre-filled syringe with needle, individually packed in carton

Route of Administration
Subcutaneous (SC) or Intravenous (IV)

Shelf Life
24 months from date of manufacture

Marketed By
Dr. Reddy's Laboratories

Molecular Formula
C944H1466N256O269S9 (for darbepoetin alfa)

Therapeutic Class
Hematopoietic growth factors

Brand Name
CRESP

Appearance
Clear, colorless, sterile solution

MRP
As printed on pack (varies by market)

Batch Number
As per packaging

ATC Code
B03XA02

About CRESP 40MCG/ 0.4 ML Injection

CRESP 40MCG/ 0.4 ML Injection is used in the treatment of anemia that may have occurred due to chronic kidney disease or chemotherapy. It works by stimulating the bone marrow to produce more red blood cells.CRESP 40MCG/ 0.4 ML Injection is a medicine that needs to be used with utmost care because it can lead to serious side effects. It is important that you seek treatment from a doctor who is experienced in providing this medical therapy. You should follow all the directions of the doctor strictly. It is given under the supervision of a healthcare professional.Common side effects include abdominal pain, high blood pressure, rash, injection site pain, breathlessness, cough, and peripheral edema. Inform your doctor if there are symptoms of very high blood pressure such as severe headache, problems with your eyesight, nausea, vomiting, or fits (seizures).Your doctor may get your blood tests done regularly to monitor the levels of salts (electrolytes such as potassium), hemoglobin, and blood cells in your blood. You should stop taking it and consult with a doctor if you develop shortness of breath or skin rash.Before taking CRESP 40MCG/ 0.4 ML Injection, tell your doctor if you have heart disease, high blood pressure, or have had a seizure or stroke. If you are pregnant or breastfeeding, or plan to become pregnant or breastfeed, consult your doctor to make sure it is safe for you. ...

How CRESP 40MCG/0.4ML Injection Works

CRESP contains darbepoetin alfa, a hematopoietic growth factor that stimulates the bone marrow to produce more red blood cells. This targeted approach helps address anemia, particularly in individuals with chronic renal failure or cancer patients undergoing chemotherapy, leading to improved oxygen transport throughout the body.

Proper Administration and Storage

This injection is administered either subcutaneously or intravenously by a healthcare professional. Each dose is carefully measured using a pre-filled syringe. It is essential to store CRESP at 2C to 8C (refrigerator) and protect it from light. Never freeze the medication, and keep it in its original carton until use.

Benefits and Suitability

CRESP is suitable for adults and children with anemia caused by chronic kidney disease or chemotherapy. The primary benefit of this treatment is the effective management of anemia and reduction in the need for blood transfusions, thereby enhancing the patient's overall quality of life and well-being.

FAQ's of CRESP 40MCG/ 0.4 ML Injection:

Q: How should CRESP 40MCG/0.4ML Injection be administered?

A: CRESP should be administered either subcutaneously (under the skin) or intravenously (into a vein) as directed by your healthcare provider. The injection is typically given once weekly or as prescribed, using the pre-filled syringe supplied in each carton.

Q: What medical conditions is CRESP Injection recommended for?

A: CRESP Injection is used for the treatment of anemia associated with chronic kidney disease and for patients undergoing chemotherapy who develop anemia due to their treatment.

Q: When can I expect to see benefits from using CRESP?

A: Response to CRESP can vary, but most patients begin to see improvements in their hemoglobin levels within several weeks of consistent use, depending on their underlying condition and response to therapy.

Q: Where should CRESP Injection be stored to ensure effectiveness?

A: CRESP should be kept refrigerated at 2C to 8C. Do not freeze the injection and keep it in its original carton to protect it from light until ready for use.

Q: What is the process for using CRESP if I miss a dose?

A: If you miss a dose, contact your healthcare provider for instructions. Do not administer a double dose to make up for the missed injection without medical advice.

Q: Who should avoid using CRESP 40MCG/0.4ML Injection?

A: CRESP should not be used by individuals with uncontrolled high blood pressure, a known allergy to darbepoetin alfa, or as determined by your physician. Always consult your doctor to determine suitability.

Q: What are the main benefits of using CRESP Injection for anemia?

A: CRESP Injection helps increase red blood cell production, reducing symptoms of anemia such as fatigue and shortness of breath, and may decrease the need for blood transfusions in eligible patients.

Tell us about your requirement